Atlas Trials

A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure

Clinical trial NCT03984591 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT03984591
Sponsor
Bispebjerg Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Systolic Heart Failure
Start date
2020-11-01
Primary completion
2028-12-31
Enrollment
7200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.